Cargando…
Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine—A New Tracer in Clinical Translation for Imaging of σ(1) Receptors
The enantiomers of [(18)F]fluspidine, recently developed for imaging of σ(1) receptors, possess distinct pharmacokinetics facilitating their use in different clinical settings. To support their translational potential, we estimated the human radiation dose of (S)-(−)-[(18)F]fluspidine and (R)-(+)-[(...
Autores principales: | Kranz, Mathias, Sattler, Bernhard, Wüst, Nathanael, Deuther-Conrad, Winnie, Patt, Marianne, Meyer, Philipp M., Fischer, Steffen, Donat, Cornelius K., Wünsch, Bernhard, Hesse, Swen, Steinbach, Jörg, Brust, Peter, Sabri, Osama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273209/ https://www.ncbi.nlm.nih.gov/pubmed/27598110 http://dx.doi.org/10.3390/molecules21091164 |
Ejemplares similares
-
In vitro and in vivo Human Metabolism of (S)-[(18)F]Fluspidine – A Radioligand for Imaging σ(1) Receptors With Positron Emission Tomography (PET)
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2019) -
Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(−)-[(18)F]Fluspidine in Glioblastoma
por: Toussaint, Magali, et al.
Publicado: (2020) -
Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ(1) Receptors in the Brain
por: Holl, Katharina, et al.
Publicado: (2014) -
Radiation dosimetry of the α(4)β(2) nicotinic receptor ligand (+)-[(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results
por: Kranz, Mathias, et al.
Publicado: (2016) -
Bridging from Brain to Tumor Imaging: (S)-(−)- and (R)-(+)-[(18)F]Fluspidine for Investigation of Sigma-1 Receptors in Tumor-Bearing Mice †
por: Kranz, Mathias, et al.
Publicado: (2018)